KFF Health Tracking Poll September 2024: Support for Reducing Prescription Drug Prices Remains High, Even As Awareness of IRA Provisions Lags September 13, 2024 Poll Finding More than two years ago President Biden signed into law Medicare drug pricing provisions in the Inflation Reduction Act. KFF’s September Health Tracking Poll examines voter’s views on these provisions and finds that large majorities of voters are unaware of the provisions despite reporting support for them.
Allowing Medicare to Negotiate Drug Prices Remains Broadly Popular Among Voters, Though Most Are Unaware of the Law and Its Projected Savings September 13, 2024 News Release Allowing Medicare to negotiate drug prices on behalf of older Americans remains broadly popular across partisans, though many voters are unaware of the new law and the billions of dollars it is expected to save in 2026, a new KFF Health Tracking Poll finds.A large majority (85%) of voters say…
Household Health Spending Calculator September 10, 2024 Interactive This interactive tool, updated with 2022 data, helps users understand health care costs vary by family size, income, insurance, and health status. Use the dropdown menus to explore scenarios and trends in household health spending.
KFF Health Tracking Poll September 2024: Harris v. Trump on Key Health Care Issues September 10, 2024 Poll Finding Prior to the first fall presidential debate, a growing share of voters see the election as a referendum on abortion access, and Vice President Harris holds a strong advantage over former President Trump on the issue. The economy and inflation remain voters’ top issue, and many want to hear the candidates address health care costs.
How Many Adults with Private Health Insurance Could Use GLP-1 Drugs September 6, 2024 Issue Brief More than two in five (42%) or 57.4 million adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues, according to a new KFF analysis. Though only about 3%…
Medical Debt: The Canary in the Coal Mine for Health Care Affordability September 5, 2024 Perspective With Vice President Harris promising to address medical debt as part of her economic plan, KFF Executive Vice President for Health Policy Larry Levitt explores why it is a symptom of the broader problem of affordable health care and reviews recent efforts to address it in this JAMA Health Forum post.
Beyond Cost, What Barriers to Health Care do Consumers Face? August 22, 2024 Issue Brief High cost-sharing and expenses not covered by insurance leave some people with expensive medical bills. But costs are not the only barriers to health care access. According to KFF’s new analysis, many adults can face logistical barriers to care, like work schedules or finding a doctor in network or appointment.…
Harris is Reframing Health as an Economic Issue August 21, 2024 From Drew Altman In his latest column, KFF President and CEO Drew Altman describes how Vice President Harris has reframed health as a pocketbook economic issue, which aligns with voters’ concern about health care costs.
FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program August 20, 2024 Issue Brief The Centers for Medicare & Medicaid Services (CMS) recently concluded the first round of negotiation for the new Medicare Drug Price Negotiation Program, which was established by the Inflation Reduction Act. These FAQs address several questions related to Medicare’s drug price negotiation program and CMS’s implementation of the new program, with a focus on the details that apply for 2026, the first year that negotiated prices will be available under this new program.
What are the Trends in Health Utilization and Spending in Early 2024? August 20, 2024 Issue Brief Recent trends in healthcare utilization and spending suggest that most spending on health services exceeds pre-pandemic levels and health costs are growing at a faster rate than in recent years. However, utilization of care has been uneven by setting and market. For example, some measures of hospital utilization remain lower…